Ethnic differences in levels of bone and cartilage biomarkers and hormonal responsiveness in nine groups of postmenopausal Asian women: The Pan-Asia Menopause (PAM) study

Climacteric

Volumn 11, Issue 1, 2008, Pages 44-54

  Holinka, C F ^a   Christiansen, C ^b   Tian, X W ^c   Ausmanas, M K ^c  

^a PharmConsult   (United States)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^c PFIZER INC   (United States)

Author keywords

Biomarkers; Bone turnover; Cartilage degradation; Menopause; PAM study; Pan Asia Menopause study

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TYPE 1 COLLAGEN TELOPEPTIDE ALPHA,ALPHA; CARBOXY TERMINAL TYPE 1 COLLAGEN TELOPEPTIDE BETA,BETA; COLLAGEN TYPE 2; COLLAGEN TYPE 2 C TELOPEPTIDE; OSTEOCALCIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN; BONE TURNOVER; CARTILAGE DEGENERATION; FEMALE; HORMONAL THERAPY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALAYSIA; OSSIFICATION; OSTEOLYSIS; PAKISTAN; POSTMENOPAUSE; PRIORITY JOURNAL; SOUTH KOREA; TAIWAN;

ADULT; AGED; ANALYSIS OF VARIANCE; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE REMODELING; CARTILAGE; COLLAGEN TYPE I; COLLAGEN TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); ETHNIC GROUPS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; OSTEOCALCIN; PEPTIDES; POSTMENOPAUSE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 38349059902     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701744886     Document Type: Article

References (32)

1. Russell-Aulet M, Wang J, Thornton JC, Colt EWD, Pierson RN Jr. Bone mineral density and mass in a cross-sectional study of white and Asian women. J Bone Miner Res 1993;8:575-82
2. Davis JW, Novotny R, Ross PD, Wasnich RD. The peak bone mass of Hawaiian, Filipino, Japanese and white women living in Hawaii. Calcif Tissue Int 1994;55:249-52
3. Tobias JH, Cook DG, Chambers TJ, Dalzell N. A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women. Clin Sci 1994;87:587-91
4. Cundy T, Cornish J, Evans MC, Gamble G, Stapleton J, Reid IR. Sources of interracial variation in bone mineral density. J Bone Miner Res 1995;10:368-73
5. Bhudhikanok GS, Wang M-C, Eckert K, Matkin C, Marcus R, Bachrach LK. Differences in bone mineral density in young Asian and Caucasian Americans may reflect differences in bone size. J Bone Miner Res 1996;11:1545-56
6. Morton DJ, Barrett-Connor E, Kritz-Silverstein D, Wingard DL, Schneider DL. Bone mineral density in postmenopausal Caucasian, Filipina, and Hispanic women. Int J Epidemiol 2003;32:150-6
7. Finkelstein JS, Lee M-LT, Sowers M, et al. Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab 2002;87:3057-67
8. Ross PD, He Y-F, Yates AJ, et al., for the EPIC Study Group. Body size accounts for most differences in bone density between Asian and Caucasian women. Calcif Tissue Int 1996;59:339-43
9. Kin K, Lee JHE, Kushida K, et al. Bone density and body composition on the Pacific Rim: a comparison between Japan-born and U.S.-born Japanese-American Women. J Bone Miner Res 1993;8:861-9
10. Sugimoto T, Tsutsumi M, Fujii Y, et al. Comparison of bone mineral content among Japanese, Koreans, and Taiwanese assessed by dual-photon absorptiometry. J Bone Miner Res 1992;7:153-9
11. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J, for the Committee of Scientific Advisors of the International Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000;Suppl 6:S2-17
12. Sarkar S, Reginster J-Y, Crans GG, Diez-Perez A, Pinette KV, Delmas PD. Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J Bone Miner Res 2004;19:394-401
13. Alexandersen P, Peris P, Guanabens N, et al. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone. J Bone Miner Res 2005;20:588-95
14. Dogan E, Posaci C. Monitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal women. Postgrad Med J 2002;78:727-31
15. Bjarnason NH, Christiansen C. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 2000;26:561-9
16. Delmas PD, Hardy P, Garnero P, Dain M-P. Monitoring individual responses to hormone replacement therapy with bone markers. Bone 2000;26:553-60
17. Garnero P. Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 2000;Suppl 6:S55-65
18. Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL. Relationship of bone turnover to bone density and fractures. J Bone Miner Res 1997;12:1083-91
19. Christgau S, Garnero P, Fledelius C, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001;29:209-15
20. Reijman M, Hazes JMW, Bierma-Zeinstra SMA, et al. A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arth Rheum 2004;50:2471-8
21. Garnero P, Charni N, Juillet F, Conrozier T, Vignon E. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann Rheum Dis 2006;65:1639-44
22. Liu H, Liao EY, Wu XP, et al. The relationships between biomarkers of age-related changes in bone turnover and bone mineral density in healthy Chinese women. Chung-Hua Nei Ko Tsa Chih Chin J Intern Med 2004;43:805-9 (in Chinese with English abstract)
23. Ausmanas MK, Holinka CF, Ling YS, Christiansen C. Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study. Climacteric 2007;10:306-13
24. Tan D, Haines CJ, Limpaphayom KK, Holinka CF, Ausmanas MK. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia menopause (PAM) study. Maturitas 2005;52:35-51
25. Haines CJ, Xing S-M, Park K-H, Holinka CF, Ausmanas MK. Prevalence of menopausal symptoms in different groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: The Pan-Asia Menopause (PAM) study. Maturitas 2005;52:264-76
26. Limpahayom KK, Darmasetiawan MS, Hussain RI, Burriss SW, Holinka CF, Ausmanas MK. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Climacteric 2006;9:204-14
27. Taechakraichana N, Holinka CF, Haines CJ, Subramaniam R, Tian XW, Ausmanas MK. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of post-menopausal Asian women: The Pan-Asia Menopause (PAM) study. Climacteric 2007;10:225-37
28. Ausmanas MK, Tan DA, Jaisamrarn U, Tian XW, Holinka CF. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study. Climacteric 2007;10:427-37
29. Rosenquist C, Bonde M, Fledelius C, Qvist P. A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin Chem 1994;40:1258-64
30. Sowers MR, Greendale GA, Bondarenko I, et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int 2003;14:191-7
31. Gennari L, Becherini L, Falchetti A, Masi L, Massart F, Brandi ML. Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms. J Steroid Biochem Mol Biol 2002;81:1-24
32. Lian K, Lui L, Zmuda JM, et al. Estrogen receptor alpha genotype is associated with a reduced prevalence of radiographic hip osteoarthritis in elderly Caucasian women. Osteoarth Cart 2007;15:972-8